Venoteks White Compression Stockings – 15-20 mmHg, 1 Pair
Optimized Product Description
Venoteks Thrombo18 compression stockings offer superior prophylaxis against venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). These medical-grade, 15-20 mmHg (Class 1 compression) stockings are designed for hospital use and are ideal for patients at high risk of blood clots. Made with a breathable, latex-free blend of 83% nylon and 17% elastane, they provide comfortable, graduated compression to improve blood circulation and reduce swelling.
Key Features & Benefits
- Effective VTE Prophylaxis: Reduces the risk of DVT and PE, supported by clinical studies.
- 15-20 mmHg Compression (Class 1): Provides optimal graduated compression for improved venous return.
- Superior Fit & Comfort: Designed for a secure, comfortable fit, minimizing slippage and restriction.
- Breathable & Moisture-Wicking: Maintains skin temperature and moisture balance for all-day comfort.
- Open Toe Design: Allows for easy monitoring of toes and prevents fungal growth.
- Durable Construction: Maintains compression properties for up to 30 days of daily wear.
- Easy Care: Machine washable and autoclave sterilizable for multiple uses.
- Latex-Free Material: Hypoallergenic and suitable for sensitive skin.
- Size Coded Heel: Facilitates easy size selection.
- Wide Thigh Design: Provides superior support and coverage.
Indications for Use
Venoteks Thrombo18 compression stockings are recommended for:
- Post-surgical patients
- Postpartum women
- Patients in intensive care units (ICUs)
- Individuals with prolonged immobility (e.g., stroke, injury, burns)
Keywords
Compression stockings, compression socks, thromboembolic stockings, venous thromboembolism, DVT, PE, deep vein thrombosis, pulmonary embolism, post-surgical, postpartum, hospital grade, medical grade, 15-20 mmHg, Class 1 compression, latex-free, thromboprophylaxis, Venoteks, Thrombo18, graduated compression, blood clot prevention, leg swelling, improved circulation.